Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3 Vulvar Neoplasms 2 Melanoma 2 Liver Metastases 2 Ulcer 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Breast Cancer Female 1

Interventions

Sorafenib 42 Bevacizumab 26 Oxaliplatin 21 Radiosurgery 19 Gemcitabine 17 Fluorouracil 15 Hepatectomy 13 lenvatinib 12 Radiofrequency Ablation 11 Nivolumab 11 Cisplatin 11 Radiotherapy 10 Doxorubicin 10 Capecitabine 10 durvalumab 9 Leucovorin 9 Blood Specimen Collection 9 atezolizumab 8 Liver Transplantation 8 Everolimus 7 Electroporation 7 pembrolizumab 6 camrelizumab 6 Sunitinib 6 Immunohistochemistry 6 Cryosurgery 6 Carboplatin 6 tremelimumab 5 sintilimab 5 apatinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Electrochemotherapy × Clear all

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡